Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1996Transfusion

The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double‐blind, controlled trial

View Full Paper
Ask AI
Bookmark
Share

Authors

TPThomas H. PricePfizer (United Kingdom)LGLawrence T. GoodnoughStanford UniversityWVWilliam R. VoglerEmory University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Price et al. (1996) studied this question.

synapsesocial.com/papers/6a8559c8f0d179eaafb554f7https://doi.org/10.1046/j.1537-2995.1996.36196190512.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy1994 · 130 citations
  2. 2Subcutaneous Recombinant Human Erythropoietin and Autologous Blood Donation Before Coronary Artery Bypass Surgery1993 · 63 citations
  3. 3Collection and transfusion of blood and blood components in the United States, 19891993 · 169 citations
  4. 4Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use1989 · 162 citations
  5. 5The Impact of Preoperative Autologous Blood Donation on Orthopaedic Surgical Practice1990 · 104 citations